Poland· PL-100140442

Aglan 15

A meloxicam product containing meloxicamum, registered in Poland by Zentiva, k.s.. The same ATC class is registered in 16 of our 19 countries.

ATC M01AC06

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedAglan 15ATCM01AC06REGISTER NO.PL-100140442PACKS LISTED5CHECKEDSeptember 27, 2026

Where it is registered

Meloxicam is registered in 16 of 19 countries.

Countries holding a registration under ATC M01AC06 (meloxicam), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 8 of them publish a price we can compare per daily dose

Meloxicam · ATC M01AC06

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of meloxicam costs, country by country.

Normalised to the WHO defined daily dose (15 mg), the median price runs from $0.14 in Spain to $0.38 in France — a ×2.6 gap.

  • 3 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Meloxicam · price per daily dose (15 mg)

USD · FX 28 Sept 2026

  • FR France$0.38
  • IT Italy$0.23
  • ES Spain$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Meloxicamum
Manufacturer
Zentiva, k.s.
Country
Poland (PL)
ATC code
M01AC06
ATC class
Meloxicam
Defined daily dose
15 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 5

2 priced
  • gtin
    05909990224883
    20 szt.
    PLN 11.67
  • gtin
    05909990610006
    30 szt.
    PLN 15.33
  • gtin
    05909990610020
  • gtin
    05909990224876
  • gtin
    05909990610013

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

442 interactions on record for meloxicam.

Graded by severity as the source publishes them — 57 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Meloxicam · interactions on record

442 records

  • 57 severe
  • 158 moderate
  • 1 minor
  • 144 info

Most severe, free to view

  • DicoumarolB01AA01severe
  • WarfarinB01AA03severe
  • DalteparinB01AB04severe
  • EnoxaparinB01AB05severe

82 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Meloxicam in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All meloxicam products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Meloxicam G.L., Movalis
  • Belgium · Meloxicam Eg, Meloxicam Sandoz
  • Bulgaria · Мелбек, Мелбек Форт
  • Cyprus · Melgesic, Melorem
  • Czechia · Melocox, Meloxicam Teva
  • Germany · Meloxicam 1 A Pharma, Meloxicam Al
  • Denmark · Meloxicam Stada, Meloxicam Teva
  • Estonia · Melox, Movalis
  • Spain · Meloxicam Cinfa, Meloxicam Normon
  • Finland · Mobic
  • France · Hexaphlogin, Meloxicam Biogaran
  • United Kingdom (Northern Ireland) · Meloxicam, Meloxicam Farmak Pharmaceuticals Uk
  • Greece · Auroxicam, Brosiral
  • Croatia · Meliam, Movalis
  • Hungary · Camelox, Meloxan
  • Ireland · Areloger
  • Italy · Meloxicam Eg, Meloxicam Mylan Generics
  • Lithuania · Melobax, Melox
  • Luxembourg · Meloxicam Eg, Mobic
  • Latvia · Melox, Mexolan
  • Malta · Melox
  • Netherlands · Meloxicam Aurobindo, Meloxicam Unichem
  • Portugal · Meloxicam Almus, Meloxicam Azevedos
  • Romania · Meloxicam Laropharm, Meloxicam Mcc
  • Sweden · Melox
  • Slovenia · Movalis
  • Slovakia · Meloxan, Meloxikam Fmk

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7740fb1-66eb-46f3-91ef-f7b6bdc5c702
GET /v1/drugs/f7740fb1-66eb-46f3-91ef-f7b6bdc5c702?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "15 mg",
  "packaging": "05909990224876 ¦ Rp ¦ 27769\n10 tabl.\n05909990224883 ¦ Rp ¦ 27771\n20 tabl.\n05909990610006 ¦ Rp ¦ 33381\n30 tabl.\n05909990610013 ¦ Rp ¦ 33382\n60 tabl.\n05909990610020 ¦ Rp ¦ 33383\n100 tabl.",
  "substance": "Meloxicamum 15 mg",
  "common_name": "Meloxicamum",
  "pl_product_id": "100140442",
  "pozwolenie_nr": "11705",
  "auth_procedure": "MRP",
  "authorisation_validity": "Bezterminowe"
}

See everything about meloxicam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.